Uncategorized - Renal and Urology News

Uncategorized

Hypertension Risk Increases as Uric Acid Levels Rise

Elevated serum uric acid (SUA) levels are associated with development of hypertension and vascular and renal target organ damage, according to a new long-term study. Investigators studied 961 parents and 570 children who were initially healthy at the time of recruitment into the STANISLAS cohort, a single-center familial longitudinal cohort that began recruiting patients in…

urine sample

Contepo NDA for Complicated UTI Resubmitted

Fosfomycin is a novel, epoxide intravenous antibiotic with a broad spectrum of Gram-negative and Gram-positive activity, including activity against multi-drug resistant (MDR) strains such as extended spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.

Renal Impairment Labeling Updates for Sofosbuvir-Based HCV Therapies

The FDA has approved updated labeling for Epclusa (sofosbuvir/velpatasvir), Harvoni (ledipasvir/sofosbuvir) and Vosevi (sofosbuvir/velpatasvir/voxilaprevir) to include updated information regarding treatment of patients with hepatitis C virus (HCV) who have severe renal impairment including those with end stage renal disease who are on dialysis.

Next post in Uncategorized